Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intralymphatic Immunotherapy in Increasing Doses up to 10 000 SQ-U -a Human Randomized Clinical Trial

NCT02679105 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT02679105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02679105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intralymphatic Immunotherapy in Increasing Doses up to 10 000 SQ-U -a Human Randomized Clinical Trial
Lead sponsor
Karolinska Institutet
Phase
Phase 2/3
Overall status
Completed
Start date
May 31, 2015
Completion date
March 31, 2019
Enrollment
38 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

rhinitis, allergic